Details of the Drug Reposition

General Information of This Drug (ID: DMM9ORD)

Drug Name
ASG-15ME   DMM9ORD
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Urothelial carcinoma DISRTNTN 2C92.0 Phase 1 [1]
Bladder cancer DISUHNM0 2C94 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT01963052) ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer. U.S. National Institutes of Health.